Coupling metal organic frameworks nanozyme with carbon nanotubes on the gradient porous hollow fiber membrane for nonenzymatic electrochemical H2O2 detection.

In this paper, we present a gradient porous hollow fiber structure integrated the signal transduction within a microspace, serving as a platform for cellular metabolism monitoring. We developed a nonenzymatic electrochemical electrode by coupling carbon nanotubes (CNT) and metal organic frameworks (MOF) nanozyme on three-dimensional (3D) gradient porous hollow fiber membrane (GPF) for in-situ detection of cell released hydrogen peroxide (H2O2). The GPF was used as a substrate for cell culture as well as the supporting matrix of the working electrode. The ultrasonically coupled CNT@MOF composite was immobilized on the outer surface of the GPF by means of pressure filtration. Notably, the MOF, acting as a peroxidase mimic, exhibits superior stability compared to traditional horseradish peroxidase. The incorporation of CNT not only provided sufficient specific surface area to improve the uniform distribution of MOF nanozyme, but also formed 3D conductive network. This network efficiently facilitates the electrons transfer during the catalytic process of the MOF, addressing the inherent poor conductivity of MOFs. The GPF-CNT@MOF nonenzymatic bioelectrode demonstrated excellent electrocatalytic performance including rapid response, satisfactory sensing selectivity, and attractive stability, which enabled the development of a robust in-situ cellular metabolic monitoring platform.

Revolutionizing Precision Medicine: Exploring Wearable Sensors for Therapeutic Drug Monitoring and Personalized Therapy.

Precision medicine, particularly therapeutic drug monitoring (TDM), is essential for optimizing drug dosage and minimizing toxicity. However, current TDM methods have limitations, including the need for skilled operators, patient discomfort, and the inability to monitor dynamic drug level changes. In recent years, wearable sensors have emerged as a promising solution for drug monitoring. These sensors offer real-time and continuous measurement of drug concentrations in biofluids, enabling personalized medicine and reducing the risk of toxicity. This review provides an overview of drugs detectable by wearable sensors and explores biosensing technologies that can enable drug monitoring in the future. It presents a comparative analysis of multiple biosensing technologies and evaluates their strengths and limitations for integration into wearable detection systems. The promising capabilities of wearable sensors for real-time and continuous drug monitoring offer revolutionary advancements in diagnostic tools, supporting personalized medicine and optimal therapeutic effects. Wearable sensors are poised to become essential components of healthcare systems, catering to the diverse needs of patients and reducing healthcare costs.

Bi-enzyme competition based on ZIF-67 co-immobilization for real-time monitoring of exocellular ATP.

Monitoring exocellular adenosine-5'-triphosphate (ATP) is a demanding task but the biosensor development is limited by the low concentration and rapid degradation of ATP. Herein, we developed a simple yet effective biosensor based on ZIF-67 loaded with bi-enzymes of glucose (GOx) and hexokinase (HEX) for effective detection of ATP. In the confined space of the porous matrix, the bi-enzymes competed for the glucose substrate in the presence of ATP, facilitating the biosensor to detect low ATP concentrations down to the micromole level (3.75 µM) at working potential of 0.55 V (vs. Ag/AgCl). Furthermore, ZIF-67 with cobalt served as a porous matrix to specifically adsorb ATP molecules, allowing it to differentiate isomers with sensitivity of 0.53 nA/µM, RSD of 5.4%, and recovery rate of 93.3%. We successfully applied the fabricated biosensor to measure ATP secreted from rat PC12 cells in the pericellular space thus realizing time-resolving measurement. This work paved the path for real-time monitoring of ATP released by cells, which will aid in understanding tumor cell glycolysis and immune responses.